Clinical Trials Logo

Coronary Artery Lesions clinical trials

View clinical trials related to Coronary Artery Lesions.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03218787 Completed - Clinical trials for Coronary Artery Lesions

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Start date: July 19, 2017
Phase: N/A
Study type: Interventional

XIENCE 90 study is a prospective, single arm, multi-center, open label trial to evaluate the safety of 3-month dual antiplatelet therapy (DAPT) in subjects at high risk of bleeding (HBR) undergoing percutaneous coronary intervention (PCI) with the approved XIENCE family of coronary drug-eluting stents. The XIENCE family stent systems include commercially approved XIENCE Xpedition Everolimus Eluting Coronary Stent System (EECSS), XIENCE Alpine EECSS, XIENCE PRO^X EECSS [rebrand of the XIENCE Xpedition Stent System and is only available outside of the United States (OUS)], XIENCE PRO^A EECSS (rebrand of the XIENCE Alpine Stent System and is only available OUS) and XIENCE Sierra EECSS of coronary drug-eluting stents.

NCT ID: NCT00967902 Completed - Clinical trials for Coronary Artery Lesions

Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent

REMEDEE
Start date: November 2009
Phase: Phase 2
Study type: Interventional

To demonstrate the safety and effectiveness of the Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) compared to the Taxus® Liberté® Stent in the treatment of coronary artery lesions.